- Exchange: Berlin
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
International Stem Cell Corp
+ Add to Watchlist0IS:GR
0.184 EUR 0.002 1.08%As of 02:01:55 ET on 05/23/2013.
Snapshot for International Stem Cell Corp (0IS)
| Open: | 0.184 | Day's Range: | 0.184 - 0.184 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 0.186 | 52wk Range: | 0.127 - 0.296 | 1-Yr Rtn: | -27.27% |
Key Statistics for 0IS
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (ttm) | - |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 220 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/09/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 0IS
Company Profile & Key Executives for 0IS
International Stem Cell Corporation develops therapeutic and research products in the biotechnolgy industry. The Company seeks to use human cells for use in the treatment of several diseases including diabetes, as well as in liver and retinal diseases.
| Andrey SemechkinCo-Chairman/CEO | John Simon CrawExec VP:Bus Dev |
| Ruslan SemechkinVP:Research & Dev | Jay NovakDir:Finance/Secy/Interim CFO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
0IS News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page